4//SEC Filing
Azoulay Salomon 4
Accession 0000950170-25-014499
CIK 0001776111other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:17 PM ET
Size
5.4 KB
Accession
0000950170-25-014499
Insider Transaction Report
Form 4
Azoulay Salomon
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-03+90,000→ 90,000 totalExercise: $10.49Exp: 2035-02-03→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option vest and become exercisable on February 3, 2026, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on such vesting date.
Documents
Issuer
MBX Biosciences, Inc.
CIK 0001776111
Entity typeother
Related Parties
1- filerCIK 0002030246
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:17 PM ET
- Size
- 5.4 KB